Andes Virus Outbreak Reported on Atlantic Cruise Ship: What You Need to Know
A cluster of severe respiratory illnesses aboard a Dutch-flagged cruise ship in the Atlantic Ocean has triggered an international public health response. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are currently monitoring the situation following reports of a deadly outbreak involving the Andes virus, a specific species of hantavirus.
As of May 2026, the outbreak has impacted a ship carrying 147 passengers and crew. Health authorities have identified seven cases so far, consisting of two laboratory-confirmed hantavirus infections and five suspected cases. The outbreak has resulted in three deaths, with one patient remaining in critical condition and three others reporting mild symptoms.
Understanding the Clinical Presentation
The symptoms associated with this outbreak have been characterized by fever and gastrointestinal issues, followed by a rapid progression to pneumonia, acute respiratory distress syndrome (ARDS), and shock. The onset of illness for those affected occurred between April 6 and April 28, 2026.
What is Hantavirus Pulmonary Syndrome (HPS)?
The Andes virus is known to lead to Hantavirus Pulmonary Syndrome (HPS), a severe and potentially deadly disease that primarily affects the lungs. While most hantaviruses are spread to humans through contact with the urine, feces, or saliva of infected rodents, the Andes virus is unique. It is the only type of hantavirus known to undergo limited human-to-human transmission, typically among those in close contact with an infected individual.
According to clinical data, HPS symptoms generally progress in two stages:
- Initial Phase: Patients may first experience fatigue, fever, and muscle aches—particularly in large muscle groups such as the thighs, hips, back, and shoulders. Approximately half of all patients also report headaches, dizziness, chills, and abdominal issues like nausea, vomiting, or diarrhea.
- Late Phase: Appearing four to 10 days after the initial symptoms, this stage is characterized by coughing and shortness of breath as the disease affects the respiratory system.
The Response and Current Risk Assessment
International and domestic health agencies are working in coordination to manage the outbreak. The CDC has been working closely with U.S. Government agencies and international partners to ensure the safe and rapid repatriation of American passengers from the affected vessel. Identified passengers have been transferred to high-containment facilities, including the Nebraska Biocontainment Unit and Emory University Hospital in Atlanta, to ensure secure treatment and monitoring.
Regarding the broader implications of this event, health officials have issued the following assessments:
- Global Risk: The WHO currently assesses the risk to the global population from this event as low.
- U.S. Risk: The CDC states that the risk of a pandemic caused by this outbreak and the overall risk to the American public and travelers remains extremely low. To date, no cases of Andes virus have been confirmed in the United States as a direct result of this cruise ship outbreak.
Public health officials continue to monitor the epidemiological situation and are providing technical assistance to ensure all potentially exposed individuals are being closely watched by health departments.
Key Takeaways
- The Outbreak: A cluster of Andes virus cases has been reported on a cruise ship in the Atlantic Ocean.
- The Virus: Andes virus can cause Hantavirus Pulmonary Syndrome (HPS) and is notable for its potential for limited human-to-human transmission.
- Current Impact: There have been seven identified cases (two confirmed) and three deaths reported among the 147 people on board.
- Public Risk: Both the WHO and CDC maintain that the risk to the general public and travelers is low to extremely low.